SA
DMRA logo
Damora Therapeutics, Inc.(DMRA)
Closing price · checked 8:21 PM ETAbout this dataData status
$23.22▼-1.08 (-4.44%)
Extended:$23.22+0.00 (+0.00%)· 8:21 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Damora Therapeutics, Inc. (DMRA)

Total Non-Current Liabilities

$974.00K

Quarterly · Period ending: · USD

DMRA logo

DMRA Total Non-Current Liabilities

Latest reported$81.00K
DMRA FY Total Non-Current Liabilities ($0.00 → $81.00K)
High-resolution chart · PNG

What is total non-current liabilities?

Long-term obligations due beyond one year.

DMRA total non-current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Damora Therapeutics, Inc. Total Non-Current Liabilities — Annual fiscal periods (USD)
Period endingTotal Non-Current Liabilities (USD)Change
81,000−94.47%
1,464,000+2,118.22%
65,999−79.88%
328,000−26.79%
448,000−17.19%
541,000+156.40%
211,000—
0—

Frequently asked questions: DMRA total non-current liabilities

What is Damora Therapeutics, Inc. (DMRA)'s current total non-current liabilities?

Damora Therapeutics, Inc. (DMRA)'s latest reported total non-current liabilities (Quarterly) is $974.00K as of Sep 30, 2026. Long-term obligations due beyond one year.

How much historical total non-current liabilities data is available for DMRA?

Stock Alarm Pro provides 8 dated annual fiscal periods observations for Damora Therapeutics, Inc. (DMRA)'s total non-current liabilities, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare DMRA's total non-current liabilities to peers or set an alert?

You can open DMRA's total non-current liabilities in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on DMRA delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.